Cross-fund · 4 holders
GALT
GALECTIN THERAPEUTICS INC
CUSIP 363225202
4
Tracked holders
$15.0M
Aggregate value
4,249,879
Shares
4
Active funds
Funds holding GALT
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $9.5M | — | +40,881 | +1.8% |
| BlackRock | Institutional | Q1 2026 | $2.2M | — | +2,679 | +0.3% |
| Millennium | Multi-Strategy | Q1 2026 | $2.2M | — | +562,926 | +239.0% |
| Citadel | Multi-Strategy | Q1 2026 | $1.0M | — | +335,860 | +1221.3% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.